Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001842952-24-000055
Filing Date
2024-07-24
Accepted
2024-07-24 16:55:48
Documents
4
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A contexttherapeutics2024spe.htm DEF 14A 153498
2 contexttherapeuticsinc_vxp.jpg GRAPHIC 196265
3 contexttherapeuticsinc_vxpa.jpg GRAPHIC 436753
4 download.jpg GRAPHIC 12205
  Complete submission text file 0001842952-24-000055.txt   1043076
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40654 | Film No.: 241138799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)